Diclofenac Sodium

双氯芬酸钠

Report date: 2026/04/08 20:02:35
NME

Base Information

Drug NameDiclofenac Sodium
Drug Alias NameDiclofenacum二氯苯胺苯乙酸Diclofenaco氯吩钠Solaraze +[47] 
ClassificationSmall molecules
Mechanisms of ActionCyclooxygenases inhibitors
TargetsCyclooxygenases
Therapy Area/IndicationsPostoperative inflammationChronic Knee PainContusions +[42] 
Global Approved IndicationsOsteoarthritisArthritis, RheumatoidSpondylitis, Ankylosing
Approved Indications in ChinaOsteoarthritisArthritis, RheumatoidSpondylitis, Ankylosing
Original Approved Country/TerritorySwitzerland
Original Approved Date1974/01/11
Country/TerritoryUnited StatesUkrainePoland +[21] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesNovartis Pharma Ag
China Registration ClassN/A

Develop Information

Active CompaniesChannel Therapeutics CorpCairo UniversityNovartis Pharma Schweiz Ag +[12] 
Inactive CompaniesEncube Ethicals Pvt LtdSandozC.H. Boehringer Sohn Ag & Co. Kg +[33] 
Active IndicationsChronic Knee PainFractures, BoneAlcoholism +[14] 
Inactive IndicationsPostoperative inflammationContusionsSoft Tissue Injuries +[28] 

Other Information

ATC CodeD11AX18M01AB05M02AA15 +[4] 
Related LinksWikipediaDrugBankKEGG